Mysuru: The GI Oncology Summit-2026 on the theme ‘Changing Dynamics in GI Oncology’ brought together leading oncologists, gastroenterologists and surgical specialists to discuss emerging approaches in diagnosis and treatment of gastrointestinal cancers.
The Summit was organised by ClearMedi Healthcare in association with GUT Club Mysore, Karnataka Chapter of Indian Society of Gastroenterology (ISG) and Cancer Research and Statistic Foundation (CRSF) at Arcor Hotel here recently.
Dr. K.G. Srinivas, Director of Oncology Service, Senior Consultant Medical Oncology and Dr. Ramakrishna, Senior Consultant Medical Gastroenterologist, ClearMedi Hospitals, Mysuru and President of GUT Club, said GI oncology was rapidly evolving, with significant advances in gastroenterology, radiology, radiation oncology, surgery and medical oncology.
The Summit aimed to share the developments with doctors and create greater awareness about advanced treatment facilities available in Mysuru.
Anuj S. Gupta, GCOO, ClearMedi Healthcare, said artificial intelligence, molecular diagnostics, immunotherapy, targeted therapies, advanced endoscopy and robotic surgery were increasingly becoming part of modern cancer care.
He stressed the importance of technology, clinical expertise and multidisciplinary teamwork in improving patient outcomes.
Gupta said GI oncology required coordinated efforts involving gastroenterologists, medical and surgical oncologists, radiation specialists, pathologists and radiologists.
ClearMedi operates eight hospitals and several cancer centres and treats more than 800 radiation patients daily across its network. Its Mysuru centre caters to more than 100 radiation patients daily.
The scientific sessions covered oesophageal, gastric, pancreatic, hepatobiliary and colorectal cancers. Experts discussed AI-assisted endoscopy, Narrow Band Imaging, chromoendoscopy, precision diagnosis, robotic surgery and newer systemic therapies.
Dr. Vasanth Siruvallur Murali of Natera, Dallas, spoke on the clinical utility of circulating tumour DNA. Ravi Kumar Sanjeevanna, Regional Director, ClearMedi Healthcare, proposed a vote of thanks.
